Ono Pharma shares soar; Nobel awarded for cancer-fighting method used in its drug

ONO PHARMACEUTICAL

02/10/2018 01:06

TOKYO, Oct 2 (Reuters) - Shares of Ono Pharmaceutical Co
 4528.T  jumped to levels not seen in over two years after a
Nobel Prize was awarded to researchers for a cancer-fighting
method used in Opdivo, a drug it co-developed with Bristol-Myers
Squibb Co  BMY.N .
    Shares of the Japanese drugmaker soared as much as 6.9
percent in early morning trade on Tuesday to hit 3,430 yen, the
highest level since August 2016.
    On Monday, American James Allison and Japanese Tasuku Honjo
won the 2018 Nobel Prize for Physiology or Medicine for
game-changing discoveries about how to harness and manipulate
the immune system to fight cancer. Their work in the 1990s has
since swiftly led to new and dramatically improved therapies for
cancers such as melanoma and lung cancer.  urn:newsml:reuters.com:*:nL8N1WH2I4

 (Reporting by Ayai Tomisawa
Editing by Chang-Ran Kim)
 ((ayai.tomisawa@thomsonreuters.com; 81-3-6441-1875; Reuters
Messaging: ayai.tomisawa.thomsonreuters.com@reuters.net))